Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Image courtesy of Shutterstock

In the medical journal The Lancet, the INTERGROWTH-21st Consortium, led by researchers at the University of Oxford, publish the final set of charts that enable healthcare professionals worldwide to assess the weight, length and head circumference of newborns from 24 to 42 weeks of gestation, and which apply to all babies, regardless of race or ethnicity.

José Villar, Professor of Perinatal Medicine at Oxford University, who led the study, said: 'The size of babies in relation to their gestational age at birth is a very important and easy to obtain marker of their health, nutritional status, chances of survival in the first years of life and future well-being. For the first time in history, health workers can now screen all babies around the world using the same charts to determine whether their growth in the womb was restricted or excessive.'

Read more

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.